Teikoku Pharma USA announced positive results of a recently completed bioavailability (BA) study examining the delivery of TPU-002RA, a 7-day rasagiline patch, for Parkinson’s disease.
TPU filed suit in March 2012 in the United States District Court for the Eastern District of Illinois, based in Chicago, alleging claims for false advertising under the Lanham Act and various state laws.
Endo announced on May 29, 2012 that it reached a settlement with Watson Pharmaceuticals
Harry W. Hind, a San Francisco pharmacist, inventor and bodysurfer, just had a way of looking at something and seeing how it could be improved. No problem could not be solved, said his friends and family members...
Teikoku Pharma USA (TPU)announced that its wholly owned subsidiary, Travanti Pharma in Mendota Heights, MN, has been merged into TPU. Prior to the merger, Travanti Pharma sold its IontoPatch® business to The Tapemark Company in West St. Paul, MN, which will continue the business and market it under the Travanti Medical brand.
Teikoku Pharma USA, Inc., (“TPU”) is pleased to announce an exclusive license agreement with Verde Environmental Technologies Inc., (“Verde”) a company aimed at developing environmentally responsible solutions for pharmaceutical disposal.
Tapemark has agreed to acquire the iontoPatch business from Travanti Pharma Inc., a wholly owned subsidiary of Teikoku Pharma USA Inc.
Teikoku Pharma USA, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept®, a leading medication for the treatment of Alzheimer’s disease.
Teikoku Pharma USA Inc. announced that it has acquired Minneapolis area based Travanti Pharma Inc, a privately held corporation that designs, develops and markets innovative drug delivery platforms...
Teikoku Pharma USA Inc., announces that it has signed an exclusive worldwide (excluding Japan) licensing agreement with Eisai Co., Ltd. to develop and commercialize a new transdermal formulation of donepezil, a leading compound for the treatment of Alzheimer's disease in the world.